FDA Approved: DAPAGLIFLOZIN — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved the original generic application for dapagliflozin, enabling a generic version of the SGLT2 inhibitor used for type 2 diabetes and related indicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

ORIG AP for DAPAGLIFLOZIN (DAPAGLIFLOZIN)